UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061441
Receipt number R000070299
Scientific Title Feasibility and Implementation of Multidisciplinary Rounds Using a Wellness Checklist in the Intensive Care Unit: A Prospective Quality Improvement Study
Date of disclosure of the study information 2026/06/15
Last modified on 2026/05/27 16:51:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Feasibility and Implementation of Multidisciplinary Rounds Using a Wellness Checklist in the Intensive Care Unit: A Prospective Quality Improvement Study

Acronym

Feasibility and Implementation of Multidisciplinary Rounds Using a Wellness Checklist in the Intensive Care Unit: A Prospective Quality Improvement Study

Scientific Title

Feasibility and Implementation of Multidisciplinary Rounds Using a Wellness Checklist in the Intensive Care Unit: A Prospective Quality Improvement Study

Scientific Title:Acronym

Feasibility and Implementation of Multidisciplinary Rounds Using a Wellness Checklist in the Intensive Care Unit: A Prospective Quality Improvement Study

Region

Japan


Condition

Condition

Critically ill patients in the Intensive Care Unit (ICU)

Classification by specialty

Intensive care medicine Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To implement multidisciplinary care rounds using a novel 4-domain wellness checklist for communicative critically ill patients admitted to the ICU, and to evaluate its feasibility and explore its preliminary effectiveness.

Basic objectives2

Others

Basic objectives -Others

Feasibility and Quality Improvement (QI)

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Feasibility of the multidisciplinary care rounds, evaluated comprehensively by the following three a priori-defined success criteria:
1. Completion rate: Care rounds are completed for 70% or more of eligible patients.
2. Consent rate: Verbal consent is obtained from 60% or more of approached eligible patients.
3. Documentation completeness rate: 80% or more of applicable items on the wellness checklist are documented without missing data.

Key secondary outcomes

1. Implementation rate of specialist-recommended interventions (proportion of recommendations by pharmacists and dietitians approved and executed by intensivists).
2. Number of preventive interventions performed.
3. Intervention success rate: proportion of identified discomforts for which interventions resulted in improvement or resolution as assessed by the next-day nurse.
4. Pre- and post-intervention changes in sleep quality (NRS-Sleep, 0-10), pain intensity (NRS, 0-10), and delirium prevalence (CAM-ICU positive rate).
5. Safety outcome: incidence of unexpected clinical deterioration or excessive fatigue-related worsening within 24 hours of the care rounds.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom Maneuver

Interventions/Control_1

Multidisciplinary care rounds are conducted twice weekly (every Monday and Friday) for communicative critically ill patients in the ICU. A multidisciplinary team consisting of a physician, nurse, pharmacist, dietitian, and physical therapist conducts bedside assessments using a novel 30-item wellness checklist covering 4 domains: physical comfort, environmental comfort, psychological and emotional support, and dignity and communication. Identified discomforts are addressed with immediate on-site interventions by the respective specialists. Outcomes are evaluated by the next-day nurse approximately 24 hours after each round. The intervention period is from June 1, 2026 to December 31, 2026.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Adult patients aged 18 years or older admitted to the ICU of St. Luke's International Hospital.
2. Patients deemed capable of communication (verbal or non-verbal).
3. Patients expected to remain in the ICU for 2 or more days.

Key exclusion criteria

1. Patients under deep sedation (incapable of communication).
2. Patients undergoing emergency procedures or in critical deterioration at the time of rounds.
3. Patients who refuse participation.
4. Patients deemed inappropriate for inclusion by the principal investigator or sub-investigators.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name Shodai
Middle name
Last name Shimano

Organization

St. Lukes International Hospital

Division name

Department of Nursing

Zip code

104-8560

Address

9-1 Akashi-cho, Chuo-ku, Tokyo, Japan.

TEL

03-3541-5151

Email

shoshima@luke.ac.jp


Public contact

Name of contact person

1st name Shodai
Middle name
Last name Shimano

Organization

St. Lukes International Hospital

Division name

Department of Nursing

Zip code

104-8560

Address

9-1 Akashi-cho, Chuo-ku, Tokyo, Japan.

TEL

03-3541-5151

Homepage URL

https://hospital.luke.ac.jp

Email

shoshima@luke.ac.jp


Sponsor or person

Institute

St. Luke's International University

Institute

Department

Personal name

Shodai Shimano


Funding Source

Organization

St. Luke's International University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

Japanese


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of St. Luke's International University

Address

10-1 Akashi-cho, Chuo-ku, Tokyo 104-0044

Tel

03-5550-2423

Email

kenkyukikaku@luke.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

St. Luke's International Hospital (Tokyo)


Other administrative information

Date of disclosure of the study information

2026 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD

No

IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2026 Year 04 Month 30 Day

Date of IRB

2026 Year 06 Month 15 Day

Anticipated trial start date

2026 Year 06 Month 15 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry

2026 Year 12 Month 31 Day

Date trial data considered complete

2027 Year 03 Month 31 Day

Date analysis concluded

2027 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2026 Year 05 Month 02 Day

Last modified on

2026 Year 05 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070299